Cited by 100Gut microbiota and healthAsthma and respiratory diseasesOral microbiology and periodontitis research

Microbiota abnormalities in inflammatory airway diseases — Potential for therapy

Gollwitzer, Eva S., Marsland, Benjamin J.·2014·Pharmacology & Therapeutics

Abstract

Increasingly the development of novel therapeutic strategies is taking into consideration the contribution of the intestinal microbiota to health and disease. Dysbiosis of the microbial communities colonizing the human intestinal tract has been described for a variety of chronic diseases, such as inflammatory bowel disease, obesity and asthma. In particular, reduction of several so-called probiotic species including Lactobacilli and Bifidobacteria that are generally considered to be beneficial, as well as an outgrowth of potentially pathogenic bacteria is often reported. Thus a tempting therapeutic approach is to shape the constituents of the microbiota in an attempt to restore the microbial balance towards the growth of 'health-promoting' bacterial species. A twist to this scenario is the recent discovery that the respiratory tract also harbors a microbiota under steady-state conditions. Investigators have shown that the microbial composition of the airway flora is different between healthy lungs and those with chronic lung diseases, such as asthma, chronic obstructive pulmonary disease as well as cystic fibrosis. This is an emerging field, and thus far there is very limited data showing a direct contribution of the airway microbiota to the onset and progression of disease. However, should future studies provide such evidence, the airway microbiota might soon join the intestinal microbiota as a target for therapeutic intervention. In this review, we highlight the major advan…

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.08.002

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Airway microbiota biodiversity is much higher in asthmatic patients with bronchial hyper-reactivity compared with healthy subjects.

    “Recent research, focused on the study of airway microbiota and their potential consequences in asthmatic patients, shows that biodiver-sity is much higher in asthmatic patients with bronchial hyper-reactivity compared with healthy subjects [84] .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gollwitzer, E. S., & Marsland, B. J.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Marsland, Benjamin J.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2014-01
Volume
141
Issue
1
Pages
32-39
ISSN
0163-7258 (ISSN-L)
OpenAlex
W1985839994
Cited by
100
References
89
Citations by year
2026: 2 · 2024: 6 · 2023: 1 · 2022: 8 · 2021: 12 · 2020: 6 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 10 · 2013: 1
FWCI
1.13
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
airway microbiome, dysbiosis, chronic lung disease, asthma, chronic obstructive pulmonary disease, cystic fibrosis, probiotics, lactobacilli, Bifidobacterium, microbiota-targeted therapy, microbiome manipulation
MeSH terms
Humans, Inflammation, Lung Diseases, Respiratory System, Probiotics, Prebiotics, Synbiotics, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review